Siblings With Ischemic Stroke Study
NCT00108940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 900
Last updated 2011-09-27
Summary
The purpose of this study is to find the genes that increase the risk of developing an ischemic stroke using DNA samples collected from concordant (stroke-affected) sibling pairs.
Conditions
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH - lead OTHER
Principal Investigators
-
James F. Meschia, M.D. · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-12-31
- Primary Completion
- 2009-06-30
- Completion
- 2011-06-30
Countries
- United States
- Canada
Study Locations
More Related Trials
-
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 ·Status: COMPLETED
-
Trial of a Secondary Stroke Prevention Program
NCT01071408 ·Status: COMPLETED ·Phase: NA
-
Mild and Rapidly Improving Stroke Study
NCT02072681 ·Status: COMPLETED
-
Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
NCT01221246 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
NCT02586233 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke
NCT00821821 ·Status: COMPLETED ·Phase: PHASE2
-
Novel Oral Anticoagulants in Stroke Patients
NCT02353585 ·Status: COMPLETED
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
NCT05445895 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
NCT04091945 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
NCT05032053 ·Status: RECRUITING
-
Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)
NCT00252239 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke
NCT02928393 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
NCT01955707 ·Status: COMPLETED ·Phase: PHASE2
-
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
NCT03907046 ·Status: RECRUITING ·Phase: PHASE3
-
Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage
NCT02670824 ·Status: COMPLETED ·Phase: PHASE1
-
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
NCT00206908 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects
NCT05403866 ·Status: COMPLETED ·Phase: PHASE2
-
Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke
NCT06559436 ·Status: RECRUITING ·Phase: NA
-
TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion
NCT01654445 ·Status: COMPLETED ·Phase: PHASE2
-
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
NCT06226805 ·Status: RECRUITING ·Phase: PHASE2
-
Factor XI Levels in Acute Ischemic Stroke
NCT00890812 ·Status: COMPLETED
-
Biomarkers of Acute Stroke in Clinic
NCT03897478 ·Status: UNKNOWN
-
Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
NCT02687191 ·Status: TERMINATED ·Phase: PHASE1